GlassScriptPhysician profile
Michael P Kelley
NPI 1639251929
$8,700.10
in general payments reported to CMS, 2019-2025
22 companies · $2,251 in 2025
The $2,251 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $68.60 · 2021: $1,048 · 2022: $772 · 2023: $1,701 · 2024: $2,154 · 2025: $2,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,094 · Food and Beverage: $3,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,094.34 |
| Food and Beverage | $3,010.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,249.17 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Inari Medical, INC. | $2,203.91 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $1,232.32 | 2022-2025 | Diamondback Coronary, Optis, Coroflow |
| Cardiovascular Systems INC. | $707.44 | 2019-2022 | |
| Penumbra, INC. | $368.33 | 2023 | Ruby Coil |
| Shockwave Medical, INC | $306.60 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $295.49 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $269.58 | 2019-2022 | |
| Abiomed | $142.12 | 2019-2025 | |
| Boston Scientific Corporation | $140.23 | 2023-2024 | Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $134.17 | 2019 | |
| Teleflex LLC | $132.40 | 2022-2023 | Trapliner |
| Pfizer INC. | $122.69 | 2019 | |
| Stryker Corporation | $101.93 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $79.94 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $62.13 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $44.10 | 2019-2022 | |
| Amarin Pharma, INC. | $34.90 | 2019 | |
| Chiesi USA, INC. | $23.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.88 | 2022 | |
| Terumo Medical Corporation | $16.35 | 2021 | |
| Medtronic Vascular, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.